In agreement with clinical observations and the role of AP-4 downregulation, our preliminary data showed that LNCaPRANKL cells overexpressing AR did have enhanced growth when inoculated as subcutaneous tumor xenografts in mice (data not shown). Here, AR is linked to neoplasm.